Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

NNVC

NNVC News

Newswire

08:35

NanoViricides Signs Master Services Agreement with OnlyOrphansCote for Orphan Drug Strategy of NV-387 for MPox, Smallpox, and Measles Treatment

14:45

NanoViricides Advances Broad-Spectrum Antiviral NV-387, Raises $6.1M in Financing

08:38

NanoViricides Inc. Files Quarterly Report, Reports Fiscal Position Strengthened by Subsequent Raise

17:11

NanoViricides shares surge 10.74% after-hours as company highlights NV-387's broad-spectrum antiviral efficacy at Pharma Partnering Summit 2025.

16:49

NanoViricides Announces $6M Registered Direct Offering at $1.68 Per Share

View More

About NNVC

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More